Publications by authors named "Hongyun Zhao"

100Publications

Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.

JAMA Netw Open 2020 Oct 1;3(10):e2015748. Epub 2020 Oct 1.

Department of Medical Oncology, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2020.15748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573680PMC
October 2020

Mendelian randomization study indicates lack of causal relationship between physical activity and lung cancer.

J Cancer Res Clin Oncol 2020 Sep 28. Epub 2020 Sep 28.

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-020-03409-1DOI Listing
September 2020

PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy.

Transl Lung Cancer Res 2020 Aug;9(4):1258-1267

Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr-20-141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481581PMC
August 2020

Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis.

J Immunother Cancer 2020 Aug;8(2)

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jitc-2020-001170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462235PMC
August 2020

The perception gap of chemotherapy-induced adverse events between doctors and cancer patients: an observational study in China.

Support Care Cancer 2020 Jul 29. Epub 2020 Jul 29.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05649-wDOI Listing
July 2020

mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients.

Transl Lung Cancer Res 2020 Jun;9(3):471-483

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2020.03.35DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354104PMC
June 2020

Effect of Al Content in Magnesium Alloy on Microstructure and Mechanical Properties of Laser-Welded Mg/Ti Dissimilar Joints.

Materials (Basel) 2020 Jun 17;13(12). Epub 2020 Jun 17.

State Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology, Harbin 150001, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ma13122743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344574PMC
June 2020

Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancer.

Clin Transl Med 2020 Jan;10(1):331-336

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ctm2.8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240844PMC
January 2020

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer.

Clin Transl Med 2020 Jun 4. Epub 2020 Jun 4.

Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ctm2.33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403827PMC
June 2020

ABI5 modulates seed germination via feedback regulation of the expression of the PYR/PYL/RCAR ABA receptor genes.

New Phytol 2020 May 30. Epub 2020 May 30.

State Key Laboratory of Crop Stress Adaptation and Improvement, School of Life Sciences, Henan University, Kaifeng, 475001, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nph.16713DOI Listing
May 2020

Anticancer drug R&D landscape in China.

J Hematol Oncol 2020 05 13;13(1):51. Epub 2020 May 13.

Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Zhongshan School of Medicine, Sun Yat-Sen University, 651 Dongfeng East Road, Guangzhou, 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-020-00877-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218822PMC
May 2020

Clinical pharmacokinetics and drug exposure-toxicity correlation study of docetaxel based chemotherapy in Chinese head and neck cancer patients.

Ann Transl Med 2020 Mar;8(5):236

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2020.01.76DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154422PMC
March 2020

Microstructure Characterization of Reversed Transformation in Cryogenically Rolled 22MnB5.

Materials (Basel) 2020 Apr 8;13(7). Epub 2020 Apr 8.

School of Materials Science and Engineering, Harbin Institute of Technology at Weihai, Weihai 264-209, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ma13071741DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179020PMC
April 2020

KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small-Cell Lung Cancer.

Oncologist 2020 Mar 5. Epub 2020 Mar 5.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2020-0067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418348PMC
March 2020

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients.

Clin Transl Med 2020 Feb 17;9(1):17. Epub 2020 Feb 17.

Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40169-020-0269-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026329PMC
February 2020

Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.

Cancer Med 2020 Mar 19;9(5):1721-1732. Epub 2020 Jan 19.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050081PMC
March 2020

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.

Ther Adv Med Oncol 2019 30;11:1758835919891652. Epub 2019 Dec 30.

Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919891652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937538PMC
December 2019

Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis.

Ann Transl Med 2019 Sep;7(18):452

Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.08.51DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803172PMC
September 2019

Risk of second primary malignancy after non-small cell lung cancer: a competing risk nomogram based on the SEER database.

Ann Transl Med 2019 Sep;7(18):439

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.09.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803229PMC
September 2019

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706).

Cancer Commun (Lond) 2019 11 7;39(1):69. Epub 2019 Nov 7.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40880-019-0414-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839103PMC
November 2019

Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasma.

Biomed Chromatogr 2020 Feb 23;34(2):e4704. Epub 2019 Dec 23.

Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bmc.4704DOI Listing
February 2020

Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy.

Int J Nanomedicine 2019 29;14:5875-5894. Epub 2019 Jul 29.

Institute of Ultrasound Imaging & Department of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, 400010 Chongqing, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJN.S212184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681566PMC
November 2019

PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.

Int J Nanomedicine 2019 23;14:5611-5622. Epub 2019 Jul 23.

Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJN.S207098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662520PMC
October 2019

Modification of the tumor response threshold in patients of advanced non-small cell lung cancer treated with chemotherapy plus targeted agents: a pooled study from five clinical trials in one institution.

Ann Transl Med 2019 Jun;7(12):253

Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.04.65DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614315PMC
June 2019

Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis.

Future Oncol 2019 Jul 26;15(21):2479-2488. Epub 2019 Jun 26.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0888DOI Listing
July 2019

Education and lung cancer: a Mendelian randomization study.

Int J Epidemiol 2019 06;48(3):743-750

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ije/dyz121DOI Listing
June 2019

Dual Targeting of Autophagy and MEK in KRAS Mutant Cancer.

Trends Cancer 2019 06 7;5(6):327-329. Epub 2019 May 7.

Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24058033193007
Publisher Site
http://dx.doi.org/10.1016/j.trecan.2019.04.003DOI Listing
June 2019

Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients.

J Cancer 2019 3;10(7):1685-1692. Epub 2019 Apr 3.

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.29319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547997PMC
April 2019

AMF siRNA treatment of keloid through inhibition signaling pathway of RhoA/ROCK1.

Genes Dis 2019 Jun 18;6(2):185-192. Epub 2018 May 18.

Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gendis.2018.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545443PMC
June 2019

Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti-PD-(L)1 Therapies in Non-Small Cell Lung Cancer.

Clin Cancer Res 2019 08 13;25(16):5015-5026. Epub 2019 May 13.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0585DOI Listing
August 2019

A Phase I/II Open-Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors.

Oncologist 2019 07 2;24(7):891-e431. Epub 2019 May 2.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656473PMC
July 2019

Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China.

Oncologist 2019 02;24(Suppl 1):S11-S20

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2019-IO-S1-s03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394776PMC
February 2019

Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.

Mol Cancer 2019 01 9;18(1). Epub 2019 Jan 9.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-019-0939-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325778PMC
January 2019

Prevalence of Burnout and Career Satisfaction Among Oncologists in China: A National Survey.

Oncologist 2019 07 19;24(7):e480-e489. Epub 2018 Dec 19.

Department of Medical Oncology, Sun Yat-sen University Cancer Centre; State Key Laboratory of Oncology in South China; Collaborative Innovation Centre for Cancer Medicine, Guangzhou, People's Republic of China

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656451PMC
July 2019

Progression-free survival and one-year milestone survival as surrogates for overall survival in previously treated advanced non-small cell lung cancer.

Int J Cancer 2019 06 7;144(11):2854-2866. Epub 2019 Jan 7.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31995
Publisher Site
http://dx.doi.org/10.1002/ijc.31995DOI Listing
June 2019

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.

Lancet Oncol 2018 10 10;19(10):1338-1350. Epub 2018 Sep 10.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30495-9DOI Listing
October 2018

Development and validation of a UPLC-MS/MS method for quantification of osimertinib (AZD9291) and its metabolite AZ5104 in human plasma.

Biomed Chromatogr 2018 Dec 12;32(12):e4365. Epub 2018 Sep 12.

Clinical Pharmacology Research Center, Peking Union Medical College Hospital, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/bmc.4365
Publisher Site
http://dx.doi.org/10.1002/bmc.4365DOI Listing
December 2018

Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.

Int J Cancer 2018 10 7;143(7):1569-1577. Epub 2018 May 7.

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31543
Publisher Site
http://dx.doi.org/10.1002/ijc.31543DOI Listing
October 2018

First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance.

J Thorac Oncol 2018 07 4;13(7):968-977. Epub 2018 Apr 4.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.025DOI Listing
July 2018

A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells.

Acta Biomater 2018 04 13;70:211-226. Epub 2018 Feb 13.

Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.actbio.2018.02.006DOI Listing
April 2018

Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy.

Nano Lett 2018 03 13;18(3):1831-1841. Epub 2018 Feb 13.

Ultrasound Department of the Second Affiliated Hospital of Chongqing Medical University , Chongqing 400010 , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.nanolett.7b05087DOI Listing
March 2018

Correction to: Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.

Clin Pharmacokinet 2018 01;57(1):103-104

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Clinical Trial Center, Sun Yat-Sen University Cancer Center, 651# Dongfeng Road East, Guangzhou, 510060, China.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40262-017-0615-4
Publisher Site
http://dx.doi.org/10.1007/s40262-017-0615-4DOI Listing
January 2018

Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study.

J Clin Pharmacol 2018 04 14;58(4):504-513. Epub 2017 Dec 14.

Sun Yat-sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1042DOI Listing
April 2018

The key role of extracellular vesicles in the metastatic process.

Biochim Biophys Acta Rev Cancer 2018 Jan 24;1869(1):64-77. Epub 2017 Nov 24.

Department of Oncology and Molecular Medicine, National Institute of Health, viale Regina Elena 299, 00161, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2017.11.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800973PMC
January 2018

Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.

Clin Lung Cancer 2017 09 27;18(5):e333-e340. Epub 2016 Oct 27.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China; State Key Laboratory of Oncology in South China, Guangzhou, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.09.006DOI Listing
September 2017

Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non-small cell lung cancer.

Onco Targets Ther 2017 21;10:1101-1110. Epub 2017 Feb 21.

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Medical Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S112158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328306PMC
February 2017

Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.

Metab Eng 2017 09 11;43(Pt B):156-172. Epub 2017 Jan 11.

Laboratory for Systems Biology of Human Diseases, Rice University, Houston, TX 77005, USA; Department of Chemical and Biomolecular Engineering, Rice University, Houston, TX 77005, USA; Department of Bioengineering, Rice University, Houston, TX 77005, USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymben.2017.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393794PMC
September 2017

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.

Chin J Cancer 2016 11 25;35(1):98. Epub 2016 Nov 25.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40880-016-0160-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124222PMC
November 2016

Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients.

Oncotarget 2016 Jun;7(25):38857-38863

Sun Yat-sen University Cancer Center, Guangdong Esophageal Cancer Institute, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122435PMC
June 2016

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo.

Mol Cancer Ther 2016 08 18;15(8):1845-58. Epub 2016 May 18.

Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China. Guangdong Esophageal Cancer Institute, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0939DOI Listing
August 2016

Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.

World J Surg Oncol 2016 May 5;14:141. Epub 2016 May 5.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-016-0878-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858859PMC
May 2016

Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.

Clin Pharmacokinet 2016 10;55(10):1205-1216

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Clinical Trial Center, Sun Yat-Sen University Cancer Center, 651# Dongfeng Road East, Guangzhou, 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-016-0395-2DOI Listing
October 2016

Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer.

Sci Rep 2016 Jan 29;6:20090. Epub 2016 Jan 29.

State Key laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep20090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731819PMC
January 2016

Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy.

Medicine (Baltimore) 2016 Jan;95(2):e2476

From the Collaborative Innovation Center for Cancer Medicine (ZH, YY, YM, YZ, CX, YH, HZ, LC, LZ); State Key Laboratory of Oncology in South China (ZH, YY, YM, HZ, LZ); Department of Medical Oncology, Sun Yat-sen University Cancer Center (ZH, WL, YY, YZ, CX, YH, LC, LZ); Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China (WL); Faculty of Health Sciences, University of Adelaide, Adelaide, Australia (DK); and Department of Pharmacy, National University of Singapore, National Cancer Center Singapore, Singapore, Republic of Singapore (AC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718276PMC
January 2016

Reply: To PMID 25546556.

J Thorac Oncol 2015 Aug;10(8):e82-3

Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangzhou, China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Sun-Yat Sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000598DOI Listing
August 2015

Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.

Sci Rep 2015 Jun 18;5:10481. Epub 2015 Jun 18.

1] Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China [2] State Key Laboratory of Oncology in South China, Guangzhou, China [3] Collaborative innovation Center for Cancer Medicine, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep10481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471724PMC
June 2015

Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe₃O₄/Calcium Phosphate Cement.

ACS Appl Mater Interfaces 2015 Jul 22;7(25):13866-75. Epub 2015 Jun 22.

†Chongqing Key Laboratory of Ultrasound Molecular Imaging, Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010 PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.5b02077DOI Listing
July 2015

Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes.

Oncotarget 2015 Jul;6(19):17738-52

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, Guangzhou, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627342PMC
http://dx.doi.org/10.18632/oncotarget.3921DOI Listing
July 2015

Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.

Clin Lung Cancer 2015 Nov 26;16(6):e165-71. Epub 2015 Mar 26.

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China; State Key Laboratory of Oncology in South China, Guangzhou, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.03.005DOI Listing
November 2015

Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.

Med Oncol 2015 Mar 22;32(3):86. Epub 2015 Feb 22.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-015-0501-6DOI Listing
March 2015

The effectiveness of RECIST on survival in patients with NSCLC receiving chemotherapy with or without target agents as first-line treatment.

Sci Rep 2015 Jan 8;5:7683. Epub 2015 Jan 8.

1] Sun-Yat Sen University Cancer Center, Guangzhou, China [2] State Key Laboratory of Oncology in South China, Guangzhou 510060, China [3] Collaborative innovation Center for Cancer Medicine, Guangzhou 510060, China.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/srep07683
Publisher Site
http://dx.doi.org/10.1038/srep07683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286759PMC
January 2015

Final overall survival results from a phase III, randomized, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804).

J Thorac Oncol 2015 Apr;10(4):655-64

*Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangzhou, China †Department of Medical Oncology, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; ‡Department of Medical Oncology, Sun-Yat Sen University Cancer Center, Guangzhou, China; §Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China; ‖Department of Radiation Therapy, Hangzhou First Pepole's Hospital, Hangzhou, China; ¶Department of Medical Oncology, Guangxi Zhuang Autonomous Region Tumour Hospital, Nanning City, China; #Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai, China; **Department of Medical Oncology, Jilin Province Tumour Hospital, Changchun, China; ††Department of Respiratory Medicine, Fujian Provincial Tumor Hospital, Fuzhou, China; ‡‡Department of Chemotherapy, Henan Province Tumour Hospital, Zhengzhou, China; §§Department of Oncology, 307 Hospital of The People' Liberation Army, Beijing, China; ‖‖Department of Medical Oncology, First Hospital of China Medical University, Shenyang, China; ¶¶Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, ##Department of Thoracic Medical Oncology, Beijing Cancer Hospital, Beijing, China; ***Department of Medical Oncology, Beijing Chest Hospital, Beijing, China; †††Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China; and ‡‡‡Department of Respiratory Disease, Peking Union Medical College, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000445DOI Listing
April 2015

The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.

Tumour Biol 2015 May 20;36(5):3389-97. Epub 2014 Dec 20.

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651# Dongfeng East Road, Guangzhou, China, 510060.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-014-2973-yDOI Listing
May 2015

A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.

Sci Rep 2014 Dec 1;4:7268. Epub 2014 Dec 1.

1] State Key Laboratory of Oncology in South China, Guangzhou, China [2] Collaborative Innovation Center for Cancer Medicine, Guangzhou, China [3] Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep07268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248273PMC
December 2014

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.

Oncotarget 2014 Dec;5(23):12189-202

State Key laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China. Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322961PMC
http://dx.doi.org/10.18632/oncotarget.2608DOI Listing
December 2014

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials.

Onco Targets Ther 2014 7;7:1851-67. Epub 2014 Oct 7.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.

View Article

Download full-text PDF

Source
http://www.dovepress.com/risk-of-treatment-related-deaths-wi
Publisher Site
http://dx.doi.org/10.2147/OTT.S68386DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199796PMC
October 2014

Multi-targeted antiangiogenic tyrosine kinase inhibitors in advanced non-small cell lung cancer: meta-analyses of 20 randomized controlled trials and subgroup analyses.

PLoS One 2014 16;9(10):e109757. Epub 2014 Oct 16.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0109757PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199622PMC
June 2015

A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.

Tumour Biol 2015 Jan 26;36(1):337-43. Epub 2014 Sep 26.

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651# Dongfeng East Road, Guangzhou, China, 510060.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/de6d9c51b3bb43b435759c3a
Web Search
http://link.springer.com/10.1007/s13277-014-2623-4
Publisher Site
http://dx.doi.org/10.1007/s13277-014-2623-4DOI Listing
January 2015

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis.

BMC Pulm Med 2014 Apr 18;14:64. Epub 2014 Apr 18.

Department of Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th floor, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2466-14-64DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998951PMC
April 2014

An investigation of symptom burden and quality of life in Chinese chemo-naïve advanced lung cancer patients by using the Instrument-Cloud QOL System.

Lung Cancer 2014 Jun 7;84(3):301-6. Epub 2014 Feb 7.

Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.01.027DOI Listing
June 2014